Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19

BACKGROUND: Coronavirus disease 2019 (COVID-19) pneumonitis associated with severe respiratory failure is associated with high mortality. The pathogenesis of COVID-19 is associated with microembolism or microvascular endothelial injuries. Here, we report that syndecan-1 (SDC-1), a component of the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Fumihiro, Oi, Yasufumi, Nakajima, Kento, Matsumura, Reo, Nakagawa, Tomoki, Miyagawa, Takao, Sakai, Kazuya, Saji, Ryo, Taniguchi, Hayato, Takahashi, Kohei, Abe, Takeru, Iwashita, Masayuki, Nishii, Mototsugu, Takeuchi, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366156/
https://www.ncbi.nlm.nih.gov/pubmed/34399775
http://dx.doi.org/10.1186/s12959-021-00308-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366156/
https://www.ncbi.nlm.nih.gov/pubmed/34399775
http://dx.doi.org/10.1186/s12959-021-00308-4

Ejemplares similares